Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8825 - 8832 of 12085 results
Congress Passes 2016 Spending Bill with Significant Funding for Food Agencies
December 19, 2015| Blog| Viewpoint
One Particular (Safe) Harbor: Safe Harbor for Massachusetts Earned Sick Time Law Ends on December 31, 2015.
December 18, 2015| Blog| Viewpoint
An Unrealistic Threat Of A Pay Cut To A High-Level Employee Is Not An Adverse Action, So Says The Fifth Circuit
December 18, 2015| Blog| Viewpoint
Law 360's Top Immigration Cases of 2015: SEC Enforcement in EB-5
December 18, 2015| Blog| Viewpoint
When The Government Comes Knocking In 2016
December 18, 2015| News
Spending and Tax Deals Brings ITC and PTC Extensions
December 17, 2015| Blog| Viewpoint
What Does GMA's SmartLabel Initiative Mean for False Advertising Litigation?
December 17, 2015| Blog| Viewpoint
The Future of Hoverboards: Federal Safety Standard or Voluntary Safety Standard?
December 17, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|